psychedelics-investing Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD 07 January
psychedelics-investing Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360 06 January
psychedelics-investing Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression and Clinical Trial Plans for Post-Traumatic Stress Disorder on January 7, 2026, 10:00am ET 09 December 2025
